Language selection

Government of Canada / Gouvernement du Canada

Search

Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age.: HP5-141/1-2022E-PDF ; HP5-141/2-2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.914493&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
TitleRecommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age.
Publication typeMonograph
Language[English]
Other language editions[French]
Later editionUpdated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration.
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Recommandations sur l'utilisation d'une première dose de rappel du vaccin Comirnaty de Pfizer-BioNTech contre la COVID-19 chez les les enfants de 5 à 11 ans.
  • At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI).
  • Includes bibliographical references (pages 14-17).
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, August 19, 2022.
  • ©2022
Description1 online resource (17 pages) + 1 summary (5 pages)
ISBN9780660450681 9780660450698
Catalogue number
  • HP5-141/1-2022E-PDF
  • HP5-141/2-2022E-PDF
Departmental catalogue number220374 (report) 220376 (summary)
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: